Sign up to save your podcasts
Or
Share JAMA Oncology : Survival and Adjuvant Chemotherapy in Early-Stage NSCLC With vs Without Clinicopathologic Features
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JAMA Oncology : Survival and Adjuvant Chemotherapy in Early-Stage NSCLC With vs Without Clinicopathologic Features
Interview with Daniel J Boffa, MD, author of Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non–Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features
View all episodes
By The JAMA Network
4.9
1212 ratings
Interview with Daniel J Boffa, MD, author of Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non–Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features
More shows like JAMA Network
View all
Science Magazine Podcast
804 Listeners
JAMA Editors' Summary
129 Listeners
HBR IdeaCast
218 Listeners
NEJM This Week
315 Listeners
JAMA Author Interviews
165 Listeners
JAMA Clinical Reviews
482 Listeners
AFP: American Family Physician Podcast
680 Listeners
JAMA Pediatrics Editors' Summary
37 Listeners
Frankly Speaking About Family Medicine
255 Listeners
The Curbsiders Internal Medicine Podcast
3,332 Listeners
JAMA Internal Medicine Author Interviews
18 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Psychiatry Author Interviews
24 Listeners
JAMA Surgery Author Interviews
6 Listeners
JAMA Medical News
87 Listeners
The Indicator from Planet Money
9,532 Listeners
Annals On Call Podcast
179 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
323 Listeners
Cardionerds: A Cardiology Podcast
407 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
18 Listeners
AMA Update
93 Listeners
NEJM AI Grand Rounds
51 Listeners